Delivery Order SPE2DB22D2214-SPE2DB25FS4NV

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,422.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ARMODAFINIL 250 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 27, 2025. While the contract was not set aside for a specific business type, Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,793.26 firm fixed-price contract is for the delivery of 4567733105 ARMODAFINIL 250 MG TABLET 30S and has an ultimate completion date of March 31, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250MG 30S, a prescription medication, with a ceiling value of $1,672.50 and a period of performance through June 12, 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,246.36, is for the supply of 4567750841 ARMODAFINIL 250 MG TABLET 30S to support federal healthcare programs. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,672.50 firm fixed-price delivery order is for the supply of 4567707530 ARMODAFINIL 250 MG TABLET 30S, with a performance period ending on March 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a Delivery Order (DO) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,304,142 units of Armodafinil 250 mg tablets, with a period of performance through February 19, 2025 and a ceiling value of $1,683.34. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Armodafinil 250 mg tablets, a medication used to treat sleep disorders. The contract has a ceiling value of $3,206.57 and a period of performance through April 8, 2025. It is a Firm Fixed Price contract, indicating a pre-determined price for the products. This order is not designated as a set-aside contract,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,795.06 firm fixed-price contract is for the supply of 4,567,908,505 units of Armodafinil 250 mg tablets. The contract has an ultimate completion date of April 15, 2025 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,356.09, is for the delivery of ARMODAFINIL 200 MG TABLET 30S, a generic pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $3,595.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4567750958 - ARMODAFINIL 250 MG TABLET 30S, and has a completion date of April 1, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation mentioned in the information provided. Amerisourcebergen Drug Corp...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB25FS4NV
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,688.25, is for the delivery of ARMODAFINIL 250 MG TABLET 30S.

The contract is a firm fixed-price delivery order, with an ultimate completion date of April 9, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any subcontractors.

This contract is not designated as a set-aside, suggesting open competition. It is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/8/25, 2:32 PM